Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New cardiovascular disease research centre launched

19.01.2005


A new London research centre for the treatment and prevention of cardiovascular disease is launched today.



Cardiovascular disease is one of the biggest contributors to the global burden of disease, and by 2020 will be the number one contributor according to figures from the World Health Organisation. In response, the International Centre for Circulatory Health (ICCH) has been set up by Imperial College London and St Mary’s NHS Trust as an international research centre to develop new treatments and preventative strategies for cardiovascular disease around the world.

The Centre will be opened by Professor Sally Davies, Director, Research and Development at the Department of Health and Sir Richard Sykes, Rector of Imperial College London. Also in attendance will be NHS ‘Heart Czar’ Roger Boyle.


Professor Peter Sever, Joint Director of the International Centre for Circulatory Health, comments: “Currently cardiovascular disease is the leading cause of death worldwide, and this is set to increase dramatically by 2020, making it vitally important that we develop better ways to treat and manage the disease. By combining Imperial’s research expertise with St Mary’s excellence in treating and managing cardiovascular disease, we hope to better leverage the strengths of both organisations.”

The ICCH’s major focus will be to investigate the causes of cardiovascular disease and develop improved preventative strategies. It will also design educational programmes to ensure best practice is shared in the UK and the developing world.

The ICCH is responsible for coordinating a number of large scale international studies looking at new treatments for cardiovascular disease, including the Anglo Scandinavian Cardiac Outcomes Trial, the results of which have already influenced international guidelines on treating hypertension and high blood pressure. The ICCH is also running a number of trials in the developing world, including a trial in Pakistan to evaluate simple preventative and treatment measures for hypertension. In addition to the research arm the ICCH is also helping develop improved patient services, including a ‘same day’ chest pain assessment unit, a specialist heart failure clinic and a stroke unit.

The Foundation for Circulatory Health, a charitable organisation, has donated £1.5 million to support the ICCH.

Jeremy Skinner, Chairman of the Board of Trustees for the Foundation for Circulatory Health, adds: “I am particularly pleased to see the money the Foundation has raised being used in such an effective way. Both Imperial and St Mary’s already have world class reputations, and combining their cardiovascular specialists in this unique collaboration will bring results which can make a real difference to the millions suffering with cardiovascular disease.”

Tony Stephenson | alfa
Further information:
http://www.imperial.ac.uk

More articles from Health and Medicine:

nachricht Vanishing capillaries
23.03.2017 | Technische Universität München

nachricht How prenatal maternal infections may affect genetic factors in Autism spectrum disorder
22.03.2017 | University of California - San Diego

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

When Air is in Short Supply - Shedding light on plant stress reactions when oxygen runs short

23.03.2017 | Life Sciences

Researchers use light to remotely control curvature of plastics

23.03.2017 | Power and Electrical Engineering

Sea ice extent sinks to record lows at both poles

23.03.2017 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>